In vivo directed differentiation of pluripotent stem cells for skeletal regeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 50, 2012, Pages 20379-20384

  Levi, Benjamin ^a   Hyun, Jeong S ^a   Montoro, Daniel T ^a   Lo, David D ^a   Chan, Charles K F ^a   Hu, Shijun ^a   Sun, Ning ^a   Lee, Min ^b   Grova, Monica ^a   Connolly, Andrew J ^a   Wu, Joseph C ^a   Gurtner, Geoffrey C ^a   Weissman, Irving L ^a   Wan, Derrick C ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG RELEASE; EMBRYONIC STEM CELL; ENGRAFTMENT; HUMAN; HUMAN CELL; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; MOUSE; MUSCLE REGENERATION; NONHUMAN; OSSIFICATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SKELETAL MUSCLE; TERATOMA; TISSUE REGENERATION;

ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL SURVIVAL; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, NUDE; OSTEOGENESIS; PLURIPOTENT STEM CELLS; SKULL; STEM CELL NICHE; TERATOMA; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS; X-RAY MICROTOMOGRAPHY;

EID: 84870933559     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1218052109     Document Type: Article

References (43)

1. Tsuji O, et al. (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stemcells for spinal cord injury. Proc Natl Acad Sci USA 107(28):12704-12709.
2. Furth ME, Atala A (2009) Stem cell sources to treat diabetes. J Cell Biochem 106(4): 507-511.
3. Thomson JA, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147. (Pubitemid 28516247)
4. Tiscornia G, Vivas EL, Izpisúa Belmonte JC (2011) Diseases in a dish: Modeling human genetic disorders using induced pluripotent cells. Nat Med 17(12):1570-1576.
5. Wernig M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151):318-324. (Pubitemid 47080337)
6. Zhao T, Zhang ZN, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212-215.
7. Apostolou E, Hochedlinger K (2011) Stem cells: iPS cells under attack. Nature 474(7350):165-166.
8. Tang C, et al. (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29(9):829-834.
9. Miura K, et al. (2009) Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27(8):743-745.
10. Cao F, et al. (2007) Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9(1):107-117. (Pubitemid 46642075)
11. Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311(5769):1880-1885.
12. Yu P, Pan G, Yu J, Thomson JA (2011) FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell 8(3):326-334.
13. Xu RH, et al. (2002) BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20(12):1261-1264.
14. Xu RH, et al. (2005) Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2(3):185-190.
15. Sun N, et al. (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106(37):15720-15725.
16. Wesselschmidt RL (2011) The teratoma assay: An in vivo assessment of pluripotency. Methods Mol Biol 767:231-241.
17. Su W, et al. (2011) Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation. J Cell Biochem 112(3):840-848.
18. Kim S, et al. (2008) In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials 29(8):1043-1053. (Pubitemid 350296313)
19. Cowan CM, et al. (2004) Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22(5):560-567. (Pubitemid 38585908)
20. Phanstiel DH, et al. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 8(10):821-827.
21. Takahashi K, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872. (Pubitemid 350138099)
22. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676. (Pubitemid 44233629)
23. Nishino K, et al. (2011) DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS Genet 7(5):e1002085.
24. Bilic J, Izpisua Belmonte JC (2012) Concise review: Induced pluripotent stem cells versus embryonic stem cells: Close enough or yet too far apart? Stem Cells 30(1):33-41.
25. Taylor RA, et al. (2006) Formation of human prostate tissue from embryonic stem cells. Nat Methods 3(3):179-181.
26. LeBleu V, et al. (2009) Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol 20(11):2359-2370.
27. Huang NF, et al. (2010) Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol 30(5):984-991.
28. Kuznetsov SA, Cherman N, Robey PG (2011) In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 20(2):269-287.
29. Arpornmaeklong P, Brown SE, Wang Z, Krebsbach PH (2009) Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 18(7):955-968.
30. Marolt D, et al. (2012) Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci USA 109(22):8705-8709.
31. Guihard P, et al. (2012) Induction of osteogenesis inmesenchymal stemcells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells 30(4):762-772.
32. Zheng Y, et al. (2012) BMP2/7 heterodimer can modulate all cellular events of the in vitro RANKL-mediated osteoclastogenesis, respectively, in different dose patterns. Tissue Eng Part A 18(5-6):621-630.
33. Levi B, et al. (2012) Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg 129(1):53-66.
34. Suzuki H, et al. (2010) Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells. BMC Cell Biol 11:72.
35. Margariti A, et al. (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci USA 109(34):13793-13798.
36. Nelson TJ, Martinez-Fernandez A, Terzic A (2010) Induced pluripotent stem cells: Developmental biology to regenerative medicine. Nat Rev Cardiol 7(12):700-710.
37. Pozzobon M, Ghionzoli M, De Coppi P (2010) ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: Current research and perspective. Pediatr Surg Int 26(1):3-10.
38. Zhao C, Tan A, Pastorin G, Ho HK (2012) Nanomaterial scaffolds for stem cell proliferation and differentiation in tissue engineering. Biotechnol Adv (Aug):9.
39. Ku SH, Lee SH, Park CB (2012) Synergic effects of nanofiber alignment and electroactivity on myoblast differentiation. Biomaterials 33(26):6098-6104.
40. Wan DC, et al. (2006) Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci USA 103(33):12335-12340. (Pubitemid 44267260)
41. Chou YF, Huang W, Dunn JC, Miller TA, Wu BM (2005) The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression. Biomaterials 26(3):285-295. (Pubitemid 38950712)
42. Levi B, et al. (2010) Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS ONE 5(6):e11177.
43. Levi B, et al. (2011) Studies in adipose-derived stromal cells: Migration and participation in repair of cranial injury after systemic injection. Plast Reconstr Surg 127(3):1130-1140.